The Middlesex-London Health Unit is currently under a province-wide Stay-At-Home Order
COVID-19 Info | Information sur la COVID-19 | COVID-19 Self-Assessment | COVID-19 Lab Results

Middlesex-London Health Unit

🔍Search
🔍
Home
Inner Nav

Influenza for Healthcare Providers

The following list of resources will assist healthcare providers during the influenza season. Please note: This web page is updated with the latest documents and links on a regular basis.

2020 Influenza Vaccine Order Form (PDF)

2020-2021 UIIP Vaccine Chart (PDF)

 

 
  • Front page of the Influenza Surveillance ReportsInfluenza Surveillance Reports
    The Middlesex London Health Unit’s Influenza Surveillance Report is published weekly during the influenza season. The purpose of the influenza surveillance report is to provide a picture of influenza activity in Middlesex London.
 

Statement on Seasonal Influenza Vaccine

  • The Canadian recommendations for Influenza vaccine are stated by the National Advisory Committee on Immunization (NACI) each year. Provinces take this information into consideration when implementing their own recommendations. 

2020-2021 Universal Influenza Immunization Program Implementation Package


Components of 2020-2021 Influenza Vaccine

The World Health Organization recommends which components should be included in influenza vaccines each year. For the 2020-2021 influenza season, in the Northern Hemisphere, these will be:

Egg-based Vaccine (FluLaval Tetra, FLUMIST® QUADRIVALENT, FLUZONE® Quadrivalent, FLUZONE® High-Dose, Influsplit Tetra)
  • an A/Guangdong-Maonan/SWL1536/2019 (H1N1)pdm09-like virus;
  • an A/Hong Kong/2671/2019 (H3N2)-like virus; 
  • a B/Washington/02/2019 (B/Victoria lineage)-like virus; and
  • *a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

*The B/Phuket/3073/2013 (B/Yamagata lineage)-like virus strain is included in quadrivalent vaccines. The preceeding three strains are included in both the trivalent and the quadrivalent vaccines. FLUZONE® High-Dose is the only trivalent vaccine listed above. 

Cell-or recombinant-based Vaccines (FLUCELVAX® QUAD)
  • an A/Hawaii/70/2019 (H1N1)pdm09-like virus;
  • an A/Hong Kong/45/2019 (H3N2)-like virus;
  • a B/Washington/02/2019 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

Influenza Vaccine Product Monographs


Seasonal Influenza Vaccine Consent Form 


Influenza Immunization Reporting Forms

For the 2020-2021 Universal Influenza Immunization Program, the Ministry of Health no longer requires vaccine utilization reports from facilities that participate.

Reporting Requirements for Health Care Worker Influenza Immunization (Long-Term Care Homes and Public Hospitals)
  • Long-term care homes and publicly hospitals are required to report health care worker immunization rates to the Health Unit by January 15th, 2021. Further details regarding collection of health care worker coverage rates, including forms, will be provided when available.
Reporting Requirements for Long-Term Care Home Resident Influenza Immunization
  • Long-term care homes are required to report resident immunization rates to the Health Unit by January 15th, 2021. Further details regarding collection of resident coverage rates, including forms, will be provided when available. 

Influenza Outbreak Tools

Line Lists

Specimen Collection and Testing

Antivirals


Surveillance

Local Surveillance

Provincial Surveillance

National Surveillance


Resources


COVID-19 Pandemic Considerations

The COVID-19 pandemic creates a series of challenges for the delivery of the seasonal influenza immunization program. The following resources have been developed by NACI to address these challenges in various health care settings. 

For additional guidance and setting specific resources, including others on immunization, visit COVID-19 Guidance and Resources for Health Care Providers and Institutions.

 
Date of creation: October 2, 2013
Last modified on: December 13, 2020